• Home
  • Contacts
  • FAQs
  • Careers

Mesoblast

  • About us
    • Company overview
    • Board of Directors
    • Corporate Governance
      • Role and Composition of the Board
      • Constitution
      • Board Committees and Charters
      • Shareholder Communication
      • Risk Management
      • Code of Conduct
      • Key Policies
    • Partners
  • Products
    • Cardiovascular diseases
    • Diabetes
    • Oncology
    • Eye disease products
    • Orthopedic Diseases
  • Technology
    • Overview
    • Scientific publications
      • Technology
      • Orthopedic
      • Cardiovascular
      • Neurological
  • Clinical trials
    • Overview
    • FAQs
  • Investors
    • Overview
    • Market announcements
    • Presentations
    • Analyst Coverage
    • Webcasts
    • Annual Reports
    • ADR trading
    • Email alerts
    • Shareholder meetings
    • Financial Tear Sheet
  • Newsroom
    • Market Announcements
      • Archives
    • Image downloads
    • Email alerts
    • Contacts

Technology

  • 13 December 2102 - Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture

  • May 2010 - Enrichment for STRO - 1 Expression Enhances the Cardiovascular Paracrine Activity of Human Bone Marrow - Derived Mesenchymal Cell Populations

  • 14 January 2003 - Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow

  • 2003 - Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone Marrow and Dental Pulp

  • June 2002 - Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression

  • 5 December 2000 - Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo

  • 1999 - Differential Cell Surface Expression of the STRO-1 and Alkaline Phosphatase Antigens on Discrete Developmental Stages in Primary Cultures of Human Bone Cells

  • 15 February 1995 - The Growth Factor Requirements of STRO-1 -Positive Human Bone Marrow Stromal Precursors under Serum-Deprived Conditions In Vitro.

  • 15 December 1994 - The STRO-1 + Fraction of Adult Bone Marow contains the Osteogenic Precursors.

  • Technology
    • Overview
    • Scientific publications
      • Technology
      • Orthopedic
      • Cardiovascular
      • Neurological

    Products

    The American Heart Association estimates 80 million American adults (approximately 1 in 3) have one or more forms of cardiovascular diseases...

    Find out more

    Technology

    Stem cell therapy is emerging as the new paradigm for treating and potentially curing human disease. It involves the use of living cells...

    Find out more

    Clinical trials

    Mesoblast is aiming to produce therapeutics for the treatment of heart conditions, blood vessel diseases of the eyes and legs bone marrow regeneration after cancer...

    Find out more
    • Privacy policy
    • Disclaimer
    • Webmail
    • Sitemap
    Copyright © 2013 Mesoblast | Website design by Mightymedia